Hamilton Thorne (CVE:HTL) Price Target Cut to C$2.75

Hamilton Thorne (CVE:HTL) had its target price cut by Stifel Nicolaus from C$3.00 to C$2.75 in a research report sent to investors on Tuesday, BayStreet.CA reports. They currently have a buy rating on the stock.

Several other analysts have also weighed in on HTL. Canaccord Genuity Group lowered their target price on shares of Hamilton Thorne from C$2.25 to C$2.20 and set a buy rating for the company in a research note on Tuesday. Pi Financial boosted their target price on shares of Hamilton Thorne from C$2.15 to C$2.25 and gave the company a buy rating in a research note on Wednesday, October 11th.

Hamilton Thorne Stock Up 4.3 %

HTL stock opened at C$1.45 on Tuesday. The company has a debt-to-equity ratio of 33.94, a current ratio of 2.63 and a quick ratio of 2.25. Hamilton Thorne has a 1-year low of C$1.25 and a 1-year high of C$1.73. The firm has a fifty day moving average price of C$1.45 and a two-hundred day moving average price of C$1.46. The firm has a market cap of C$212.89 million, a price-to-earnings ratio of 48.33 and a beta of 0.54.

Hamilton Thorne Company Profile

Hamilton Thorne Ltd. develops, manufactures, and sells precision instruments, consumables, software, and services for the assisted reproductive technologies (ART), research, and cell biology markets. It offers precision laser systems, imaging systems, and other equipment and consumables for the ART and developmental biology research markets.